Journal
BMC CARDIOVASCULAR DISORDERS
Volume 19, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12872-019-1194-0
Keywords
Apolipoprotein E polymorphism; Type 2 diabetes mellitus (T2DM); Cardiovascular disease (CVD)
Categories
Funding
- Science and Technology Program of Meizhou [2018B027]
- Key Scientific and Technological Project of Meizhou People's Hospital [MPHKSTP-20180101, MPHKSTP-20170101]
Ask authors/readers for more resources
Background The role of apolipoprotein E gene (APOE) in lipid metabolism has been well established, and APOE is associated with the risk of cardiovascular disease (CVD) and diabetes mellitus (DM). However, the relationship between APOE polymorphisms and type 2 diabetes (T2DM) with or without CVD remains unclear. Methods In this cross-sectional study, a total of 924 participants including 211 controls (CVD-T2DM-), 247 T2DM patients with CVD (CVD-T2DM+), 232 CVD patients without T2DM (CVD + T2DM-) and 234 T2DM patients with CVD (CVD + T2DM+), were genotyped using chip platform. The association between APOE polymorphisms and T2DM patients with or without CVD was analyzed by univariable and multivariable logistic analysis. Results The present study showed that the frequency of E3/E4 increased in T2DM patients with CVD (p < 0.01). The epsilon 4 allele was higher in CVD patients without T2DM (p < 0.01) and T2DM patients with CVD (p < 0.01) as compared with the controls. Conclusions The subjects carrying epsilon 4 allele have increased risk of CVD and T2DM, and exhibit higher level of lipid profiles.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available